Skip to main content

Day: March 27, 2025

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the American Society for Gastrointestinal Endoscopy (ASGE) updated its guideline on the diagnosis and management of gastroesophageal reflux disease (GERD) to include Transoral Incisionless Fundoplication (TIF 2.0) and TIF 2.0 Consecutive Transoral Incisionless Fundoplication (cTIF)* procedures as evidence-based approaches to care. GERD occurs when stomach acid flows into the esophagus, causing irritation of the tissue lining. Uncomfortable symptoms can include heartburn, upper stomach or chest pain, trouble swallowing, and chronic cough. A common chronic condition,...

Continue reading

TEN Ltd. Reports Profits for the 12 Months and Fourth Quarter Ended December 31, 2024 and Announces Common Share Dividend

Dynamic 21 vessel expansion – 36% dwt growth – 82 vessel proforma fleet. Doubling minimum contracted revenues to $4.0 billion Adjusted EBITDA of $400 million and Net income of $176 million for 2024   Annual EPS of $5.03 and $0.42 for the 2024 fourth quarter Nine DP2 shuttle tankers on long-term employment to Brazil’s Transpetro with expected contracted revenues of $2.0 billion positioning TEN as one of the largest shuttle tankers owners in the world – Proforma Shuttle fleet of 16 vessels all on fixed employment Sale of 2009-built suezmax generates $30.0 million in free cash as part of ongoing fleet renewal Uninterrupted dividend payments since NYSE listing in 2002 Market fundamentals remain strong ATHENS, Greece, March 27, 2025 (GLOBE NEWSWIRE) — TEN, Ltd (TEN) (NYSE: TEN) (the “Company”) today reported results...

Continue reading

ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

KEY HIGHLIGHTS:Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025.Regulatory path for VAR 200’s lead indication, focal segmental glomerulosclerosis (FSGS), expected to be shorter based on FDA’s alignment with data supporting proteinuria reduction as a clinical trial endpoint for approval of FSGS drugs (Parasol Initiative).Obesity proof-of-concept studies with Inflammasome ASC Inhibitor IC 100 in diet-induced obesity (DIO) mouse models are planned to begin H1-2025. Investigational New Drug Application (IND) for IC 100 is anticipated to be submitted H2-2025, followed by initiation of a Phase 1 clinical trial in healthy overweight subjects. Preclinical study funded by The Michael J. Fox Foundation (MJFF) to evaluate the potential...

Continue reading

Carlyle Secured Lending, Inc. Closes Merger with Carlyle Secured Lending III

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) — Carlyle Secured Lending, Inc. (“CGBD”) (NASDAQ: CGBD) announced today the closing of its previously announced merger with Carlyle Secured Lending III (“CSL III”) with CGBD as the surviving company. Based on March 25, 2025 financial data, the combined company has more than $2.8 billion of assets. In connection with the closing of the merger, CSL III shareholders received 18,935,108 shares of CGBD common stock for each common share of CSL III based on the final exchange ratio and payment of cash in lieu of fractional shares. Prior to the closing of the merger, Carlyle Investment Management L.L.C. (“CIM”), a wholly owned subsidiary of Carlyle, exchanged its shares of CGBD convertible preferred stock for CGBD common stock at current NAV, eliminating the risk of dilution from the potential...

Continue reading

Kartoon Studios to Report Q4 2024 Results Pre-Market on March 31

CEO Andy Heyward and CFO Brian Parisi to Host Video Q&A Session with Investor Bryce McNallie of the Popular McNallie Money Podcast BEVERLY HILLS, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) today announced that the company will report Q4 2024 results pre-market on March 31. A press release will be available via Globe Newswire and posted at www.kartoonstudios.com. In addition, Kartoon Studios will stream a video Q&A session with CEO Andy Heyward and CFO Brian Parisi, hosted by Bryce McNallie of the popular McNallie Money Podcast. The interview will be posted shortly after Q4 results are announced via the company’s social media channels, including X, LinkedIn, and Instagram. It can also be viewed via the company’s YouTube Channel and the McNallie Money Podcast. About Kartoon Studios Kartoon...

Continue reading

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has expanded access to its fingerprint drug testing in Spain and Andorra through a strategic collaboration with Detecto, a division of Spanish distributor MTB Distribuciones Tecnologicas SL (“MTB”). MTB established Detecto following decades of experience in clinical distribution, recognizing the market’s evolving needs and increasing demand for drug testing across various sectors....

Continue reading

Liberty Defense Continues Rapid Commercial Scaling Channel Partnerships Selecting Point Security for HEXWAVE US Aviation & Urban Security Markets

WILMINGTON, Mass., March 27, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: LD2A), a leading technology provider of AI-based next generation detection solutions for concealed non-metallic and metallic weapons and threats, is pleased to announce it has entered into a strategic non-exclusive distribution agreement with Lexington, North Carolina based Point Security Inc., to introduce HEXWAVE™ to US airports. Point Security has 30 years of experience in the sale, rental, and service of checkpoint security equipment. As part of the distribution agreement Point Security will add the HEXWAVE walkthrough people screening system, which uses AI and machine learning to seamlessly detect weapons and other threats in real-time, to its diverse security equipment...

Continue reading

LPL Financial Welcomes Oxford Oaks Capital to Linsco Channel

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Austin Greer, CRPS ®, has joined LPL’s employee advisor channel, Linsco by LPL Financial, to launch Oxford Oaks Capital of LPL Financial. He reported serving approximately $600 million in advisory, brokerage and retirement plan assets* and joins LPL from UBS. Based in the Linsco office in Franklin, Tenn., Greer originally set out to become a high school English teacher before following his father’s footsteps into financial services. He appreciates the educational component of his role as a financial advisor to help clients understand their investments. Now with more than 17 years of industry experience, Greer focuses on retirement income planning, as well as tax and estate planning for high-net-worth clients, including business...

Continue reading

ParaZero Signed Non-Binding Letter of Intent to Acquire a Company that Specializes in Counter-Drone Systems and Autonomous Drone Technologies

Proposed acquisition would bring advanced space technologies and deep-space navigation expertise into ParaZero’s innovation portfolio TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (“ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced the signing of a non-binding Letter of Intent (LOI) to acquire 100% of the issued and outstanding share capital of Lulav Space Ltd. (“Lulav”), a company specializing in the development of counter drone systems, AI, space-grade autonomous systems, and computer vision. Lulav Space was founded in 2021 with the goal of developing vision-based precision navigation systems for space robotics missions. Lulav specializes in advanced guidance, navigation and control technologies...

Continue reading

Innovative MACOM Solutions on Display at OFC 2025

LOWELL, Mass., March 27, 2025 (GLOBE NEWSWIRE) — MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, will showcase its latest connectivity solutions at Booth 2028, during OFC 2025 from April 1 to 3, 2025 in San Francisco, California. MACOM will host live demonstrations and present its extensive portfolio of optical and copper connectivity solutions, including lasers, laser and modulator drivers, photodiodes, transimpedance amplifiers (TIAs), linear equalizers, optical clock recovery (OCR) modules, high speed optical receiver solutions, optical post amplifiers and advanced clock and data recovery integrated circuits. Demonstrations to include:3.2 Terabit Transmit Solutions: Demonstrating capabilities to support 400G per lane Pulse Amplitude Modulation (PAM) transmission for single mode fiber...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.